DONOR-RELATED CHARACTERISTICS AS PREDICTORS OF SUSTAINED VIROLOGIC RESPONSE TO ANTIVIRAL THERAPY IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION

被引：0
|
作者：
Iemmolo, R. M. [1 ]
Marino, M. [1 ]
Montalti, R. [1 ]
Ponziani, F. [2 ]
Vigano, R. [3 ]
De Martin, E. [4 ]
Donato, M. F. [3 ]
Rendina, M. [5 ]
Morelli, M. C. [6 ]
Di Paolo, D. [7 ]
Fornasiere, E. [8 ]
Migliorasi, L. [9 ]
Giannelli, V. [10 ]
Fagiuoli, S. [11 ]
Gerunda, G. E. [1 ]
机构：
[1] Univ Policlin Modena, Azienda Osped, Liver & Multivisceral Transplantat Ctr, Modena, Italy
[2] Univ Cattolica Sacro Cuore, Rome, Italy
[3] Osped Niguarda Ca Granda, Milan, Italy
[4] Univ Padua, Sch Med, Padua, Italy
[5] Univ Hosp Bari, Bari, Italy
[6] St Orsola Malpighi Hosp, Bologna, Italy
[7] Univ Roma Tor Vergata, Rome, Italy
[8] Univ Udine, I-33100 Udine, Italy
[9] San Camillo Spallanzani Hosp, Rome, Italy
[10] Univ Roma La Sapienza, Rome, Italy
[11] Osped Riuniti Bergamo, I-24100 Bergamo, Italy
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)60553-9
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
551
引用
收藏
页码：S225 / S225
页数：1
相关论文
共 50 条
  • [41] Novel defective HCV clones influence a resistance to antiviral therapy in recurrent hepatitis C after living-donor liver transplantation
    Iwai, Akio
    Marusawa, Hiroyuki
    Takada, Yasutsugu
    Egawa, Hiroto
    Nabeshima, Motoshige
    Chiba, Tsutomu
    GASTROENTEROLOGY, 2006, 130 (04) : A32 - A32
  • [42] Reduced-Dose Telaprevir-Based Triple Antiviral Therapy for Recurrent Hepatitis C After Living Donor Liver Transplantation
    Ikegami, Toru
    Yoshizumi, Tomoharu
    Kato, Masaki
    Yamamoto, Satomi
    Fukuhara, Takasuke
    Matsuura, Yoshiharu
    Nakamura, Shota
    Itoh, Shinji
    Shirabe, Ken
    Maehara, Yoshihiko
    TRANSPLANTATION, 2014, 98 (09) : 994 - 999
  • [43] Liver Pathologic Changes After Direct-Acting Antiviral Agent Therapy and Sustained Virologic Response in the Setting of Chronic Hepatitis C Virus Infection
    Celli, Romulo
    Saffo, Saad
    Kamili, Saleem
    Wiese, Nicholas
    Hayden, Tonya
    Taddei, Tamar
    Jain, Dhanpat
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 2021, 145 (04) : 419 - 427
  • [44] Alcohol Use and Sustained Virologic Response to Hepatitis C Virus Direct-Acting Antiviral Therapy
    Cartwright, Emily J.
    Pierret, Chloe
    Minassian, Caroline
    Esserman, Denise A.
    Tate, Janet P.
    Goetz, Matthew B.
    Bhattacharya, Debika
    Fiellin, David A.
    Justice, Amy C.
    Lo Re, Vincent
    Rentsch, Christopher T.
    JAMA NETWORK OPEN, 2023, 6 (09) : E2335715
  • [45] Is Early Antiviral Therapy for Recurrent Hepatitis C After Liver Transplantation Superior to Later Treatment? The Answer Is No
    Roche, Bruno
    Samuel, Didier
    LIVER TRANSPLANTATION, 2011, 17 (05) : 488 - 491
  • [46] END OF TREATMENT RESPONSE TO ANTIVIRAL THERAPY STABILIZES FIBROSIS IN RECURRENT HEPATITIS C AFTER LIVER TRANSPLANTATION FOR AT LEAST ONE YEAR
    Selzner, Nazia
    Guindi, Maha
    Leslie, Lilly
    Adeyi, Oyedele
    Therapondos, George
    Kashfi, Arash
    Selzner, Markus
    Ian, McGilvray
    Greig, Paul
    Cattral, Mark
    Grant, David
    Levy, Gary
    Renner, Eberhard L.
    LIVER TRANSPLANTATION, 2008, 14 (07) : S206 - S206
  • [47] RECURRENT HEPATITIS C AFTER ANTIVIRAL THERAPY
    Reddy, Y. K.
    Thornton, L. C.
    Waters, B.
    JOURNAL OF INVESTIGATIVE MEDICINE, 2019, 67 (02) : 589 - 589
  • [48] Hepatitis C "true" late relapse beyond 48 weeks of sustained virologic response after direct acting antiviral therapy
    Klag, Thomas
    Dietz, Julia
    Werner, Christoph R.
    Schwarz, Julia M.
    Lauer, Ulrich M.
    Beck, Robert
    Malek, Nisar P.
    Sarrazin, Christoph
    Berg, Christoph P.
    JOURNAL OF HEPATOLOGY, 2017, 66 (04) : 862 - 863
  • [49] ANTIVIRAL THERAPY OF HEPATITIS C WITH 1 GENOTYPE AFTER LIVER TRANSPLANTATION
    Tsiroulnikova, O. M.
    Umrik, D. V.
    VESTNIK TRANSPLANTOLOGII I ISKUSSTVENNYH ORGANOV, 2018, 20 (03): : 105 - 115
  • [50] Hepatitis C virus reinfection in patients on haemodialysis after achieving sustained virologic response with antiviral treatment
    Liu, Chen-Hua
    Peng, Cheng-Yuan
    Kao, Wei-Yu
    Yang, Sheng-Shun
    Shih, Yu-Lueng
    Lin, Chin-Lin
    Tsai, Meng-Kun
    Lee, Chih-Yuan
    Chang, Chun-Chao
    Wu, Jo-Hsuan
    Liu, Chun-Jen
    Su, Tung-Hung
    Tseng, Tai-Chung
    Chen, Pei-Jer
    Kao, Jia-Horng
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 55 (04) : 434 - 445
12345